{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:23Z","timestamp":1787067863793,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,6,25]],"date-time":"2007-06-25T00:00:00Z","timestamp":1182729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,6,25]],"date-time":"2007-06-25T00:00:00Z","timestamp":1182729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/sj.bmt.1705754","type":"journal-article","created":{"date-parts":[[2007,6,25]],"date-time":"2007-06-25T05:29:44Z","timestamp":1182749384000},"page":"451-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole"],"prefix":"10.1038","volume":"40","author":[{"given":"S","family":"Trifilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Frankfurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Evens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,25]]},"reference":[{"key":"BF1705754_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1086\/432060","volume":"41","author":"M Nucci","year":"2005","unstructured":"Nucci M, Marr KA . Emerging fungal infections. Clin Infect Dis 2005; 41: 521\u2013526.","journal-title":"Clin Infect Dis"},{"key":"BF1705754_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","volume":"18","author":"N Singh","year":"2005","unstructured":"Singh N, Paterson DL . Aspergillus Infections in transplant patients. Clin Microbiol Rev 2005; 18: 44\u201369.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"BF1705754_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1182\/asheducation-2001.1.392","volume":"2001","author":"K. M. Sullivan","year":"2001","unstructured":"Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin RH et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: The Centers for Disease Control, Infectious Disease Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology (Am Soc Hematol Educ Program) 2001, 392\u2013421.","journal-title":"Hematology"},{"key":"BF1705754_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/sj.bmt.1704423","volume":"33","author":"SM Trifilio","year":"2004","unstructured":"Trifilio SM, Verma A, Mehta J . Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplant 2004; 33: 735\u2013739.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705754_CR5","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1128\/AAC.01053-05","volume":"50","author":"D Andes","year":"2006","unstructured":"Andes D, Forrest A, Lepak A, Nett J, Marchillo K, Lincoln L . Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob Agents Chemother 2006; 50: 2374\u20132383.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705754_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408\u2013415.","journal-title":"N Engl J Med"},{"key":"BF1705754_CR7","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","volume":"47","author":"L Ostrosky-Zeichner","year":"2003","unstructured":"Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW et al. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrobiol Agents Chemother 2003; 47: 3149\u20133154.","journal-title":"Antimicrobiol Agents Chemother"},{"key":"BF1705754_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJM200201243460403","volume":"346","author":"TJ Walsh","year":"2002","unstructured":"Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225\u2013234.","journal-title":"N Engl J Med"},{"key":"BF1705754_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1128\/AAC.50.4.1570-1572.2006","volume":"50","author":"J Smith","year":"2006","unstructured":"Smith J, Safdar N, Knasinski V, Simmons W, Bhavnani SM, Ambrose PG et al. Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother 2006; 50: 1570\u20131572.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705754_CR10","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","volume":"103","author":"KA Marr","year":"2004","unstructured":"Marr KA, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee SA et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004; 103: 1527\u20131533.","journal-title":"Blood"},{"key":"BF1705754_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/sj.bmt.1704828","volume":"35","author":"S Trifilio","year":"2005","unstructured":"Trifilio S, Ortiz R, Pennick G, Verma A, Pi J, Stosor V et al. Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005; 35: 509\u2013513.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705754_CR12","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1128\/AAC.47.7.2348-2350.2003","volume":"47","author":"GJ Pennick","year":"2003","unstructured":"Pennick GJ, Clark M, Sutton DA, Rinaldi MG . Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob Agents Chemother 2003; 47: 2348\u20132350.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705754_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2006.01.018","volume":"55","author":"GT Siwek","year":"2006","unstructured":"Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M et al. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microbiol Infect Dis 2006; 55: 209\u2013212.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"BF1705754_CR14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","volume":"96","author":"KA Marr","year":"2000","unstructured":"Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers ME et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000; 96: 2055\u20132061.","journal-title":"Blood"},{"key":"BF1705754_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634\u2013653.","journal-title":"Clin Infect Dis"},{"key":"BF1705754_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.idc.2006.06.003","volume":"20","author":"DP Kontoyiannis","year":"2006","unstructured":"Kontoyiannis DP, Lewis RE . Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006; 20: 581\u2013607.","journal-title":"Infect Dis Clin North Am"},{"key":"BF1705754_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1056\/NEJM200402263500923","volume":"350","author":"FM Marty","year":"2004","unstructured":"Marty FM, Cosimi LA, Baden LR . Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950\u2013952.","journal-title":"N Engl J Med"},{"key":"BF1705754_CR18","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/428780","volume":"191","author":"DP Kontoyiannis","year":"2005","unstructured":"Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case\u2013control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350\u20131360.","journal-title":"J Infect Dis"},{"key":"BF1705754_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/sj.bmt.1704485","volume":"33","author":"A Verma","year":"2004","unstructured":"Verma A, Williams S, Trifilio S, Zembower T, Mehta J . Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplant 2004; 33: 1065\u20131066.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705754_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/315193","volume":"181","author":"KA Marr","year":"2000","unstructured":"Marr KA, Seidel K, White TC, Bowden RA . Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309\u2013316.","journal-title":"J Infect Dis"},{"key":"BF1705754_CR21","unstructured":"www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3792b2_02_FDA-voriconazole.htm (Accessed 9 November 2006; page search term \u2018Voriconazole Efficacy Response Assessment\u2019)."},{"key":"BF1705754_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","volume":"44","author":"MA Pfaller","year":"2006","unstructured":"Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006; 44: 819\u2013826.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"BF1705754_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1439-0507.1989.tb02299.x","volume":"32","author":"MA Boogaerts","year":"1989","unstructured":"Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beule K . Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 1989; 32 (Suppl 1): 103\u2013108.","journal-title":"Mycoses"},{"key":"BF1705754_CR24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1128\/AAC.38.6.1303","volume":"38","author":"J Berenguer","year":"1994","unstructured":"Berenguer J, Ali NM, Allende MC, Lee J, Garrett K, Battaglia S et al. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. Antimicrob Agents Chemother 1994; 38: 1303\u20131308.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705754_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1439-0507.1999.00505.x","volume":"42","author":"A Glasmacher","year":"1999","unstructured":"Glasmacher A, Hahn C, Leutner C, Molitor E, Wardelmann E, Losem C et al. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole. Mycoses 1999; 42: 443\u2013451.","journal-title":"Mycoses"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705754","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T20:33:02Z","timestamp":1648067582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,25]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BF1705754"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705754","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,25]]},"assertion":[{"value":"16 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}